At DermInnovate, we conduct groundbreaking research in dermatology, with future hopes of collaborating with esteemed institutions like UCSD. Our focus is on developing targeted therapies for eczema and MRSA.

​

“DermInnovate Labs was born out of necessity — to protect my daughter’s health and the health of others living with chronic skin conditions. Every discovery we make brings us closer to a cure, a vaccine, and a world where skin health is not a privilege, but a promise.”
— Dania Lajuana Matthews Scott, Founder & Chief Innovator

​

🔬 Research & Innovation at DermInnovate Labs

Advancing Dermatology Through Biotechnology, AI, and Compassionate Science

Our Mission in Research

At DermInnovate Labs LLC, our research is driven by a singular purpose — to develop safe, effective, and accessible skin health solutions for chronic and underserved conditions.

Founded in Carlsbad, California, our biotechnology lab specializes in AI-driven dermatological innovation, microbiome science, and biocompatible formulation design.

We merge clinical dermatology, data modeling, and ethical biotechnology to accelerate the discovery of advanced therapies for inflammatory skin diseases — starting with eczema and MRSA (Methicillin-Resistant Staphylococcus aureus).

Research Focus Areas

🧬 1. Eczema Vaccine & Immunotherapy Development

Our leading research initiative explores biotechnological pathways for an eczema vaccine through antigen-mimicry and immune modulation.
We aim to:

• Identify molecular targets for eczema immune response control

• Model potential vaccine candidates using AI-assisted simulation

• Establish safe, scalable formulation protocols

🧫 2. MRSA Prevention & Skin Microbiome Restoration

DermInnovate Labs is investigating topical and probiotic-based interventions to combat antibiotic-resistant skin infections.
Our work focuses on:

• Targeting MRSA colonization through microbiome modulation

• Testing antimicrobial peptides and natural compounds

• Reducing infection risk in immunocompromised and eczema-prone patients

💧 3. Barrier Repair & Regenerative Formulations

Our R&D pipeline includes next-generation barrier ointments and microbiome-calming serums designed to restore the skin’s protective ecosystem.
Each prototype is engineered through bioinformatics and ingredient compatibility modeling to ensure safety and efficacy.

🌍 4. Sustainable Dermatology Innovation

We are committed to building a sustainable, ethical dermatology future by:

• Using biodegradable, cruelty-free materials

• Partnering with green chemistry suppliers

• Reducing environmental impact through precision formulation

Technology Platform

DermInnovate Labs leverages a digital-first research model until our physical lab opens in Carlsbad, CA. Our proprietary R&D framework integrates:

• AI formulation algorithms for predictive compound testing

• 3D molecular modeling for ingredient interactions

• Cloud-based clinical simulations for safety and efficacy forecasting

This hybrid approach allows us to perform preclinical studies, analyze large data sets, and prepare grant-ready research models for rapid funding activation.

Our Current Projects (2025–2026)

Project TitleFocusStage

Barrier Restore OintmentEczema-related barrier repairPrototype modeling

Dry Shower No-Rinse WipesWaterless hygiene innovationEarly formulation

Eczema Cleansing KitMulti-step chronic skin management systemIngredient analysis

AI Skin Diagnostics ModelPredictive dermatology interfaceAlgorithm testing

Eczema & MRSA VaccineImmunotherapy + microbial defensePre-clinical simulation

Collaboration & Grant Partnerships

DermInnovate Labs is actively seeking:

• NIH & NSF research partnerships

• SBIR/STTR small business innovation grants

• Healthcare foundations and university collaborators

• B2B biotech partnerships and licensing opportunities

Our research model aligns with federal innovation goals in:

• Biomedical innovation

• Minority- and women-led STEM entrepreneurship

• Public health advancement

• Digital transformation in life sciences

We welcome collaboration with:

• Academic research institutions

• Federal research programs

• Private-sector investors

• Nonprofit health organizations

📧 To collaborate or sponsor research: grants@derminnovatelabs.com

Commitment to Safety, Ethics & Equity

Every DermInnovate Labs research initiative follows:

• FDA-aligned safety principles

• Good Manufacturing Practice (GMP) standards

• IRB-consulted ethical review processes

• Diversity and inclusion in clinical representation

Our work ensures that innovation in skincare reflects the full spectrum of human skin.

Why Fund DermInnovate Labs

DermInnovate Labs stands at the intersection of biotechnology, data science, and compassionate dermatology.
We are not just building products — we are building a future where chronic skin conditions can be cured, prevented, and understood.

Your grant or partnership accelerates:

• Life-saving dermatological breakthroughs

• Inclusive, women-led biotech entrepreneurship

• Community health impact through education and access

Funding innovation that heals — today, for tomorrow’s skin.